7 Days In May is more than just an annual charity cycling event. In memory of Lorraine Townley, her surviving children have created a charitable foundation that is dedicated to raising awareness and funds to cure pancreatic cancer.
How The Foundation Is Structured
For simplicity, low administration costs, and to have a viable infrastructure, we partnered with the Toronto Community Foundation as the parent organization for the 7 Days In May Foundation. Working with the Toronto Community Foundation provides a transparent, fully audited, well funded and reputable organization that ensures our funds are secure and our commitments can be fulfilled. So far, they have been a helpful, involved and enthusiastic partner and we are happy to be part of their family.
The 7 Days In May Foundation is comprised of two parts – a flow through fund (which is where all of the money raised through the 7 Days In May cycling event are assigned) and a “donor advised fund” which is funded entirely by the Townley family and is an endowment engine that, amongst other things, covers the administration and other costs associated with the flow through fund allowing 100% of what is donated to go directly to the chosen charitable cause that is selected each year. You can learn more about the Toronto Community Foundation (TCF) and, specifically, the 7 Days In May Foundation by going to the TCF web site through the links provided on this page.
How Funds Are Collected
In 2014, there are two ways that funds will be collected for 7 Days In May.
- You may donate directly to the fund by going to the 7 Days In May Foundation page on the TCF web site and making a donation. Receipts will be issued by the TCF and mailed to you at a later date. At this time, the TCF is not able to issue on line tax receipts, although they are working on that and should have it in place in time for our 2014 activities. Or,
- Donations can be made to any of our participating riders in the 7 Days In May event. All of our fund raising riders are listed on the “Donate” page within this site. By choosing any rider, you will be directed to the Canada Helps web site that is hosting the giving page for each rider this year. If you choose to donate in this manner, you will receive an on line tax receipt immediately issued by Canada Helps, which has a direct affiliation with the TCF. While this seems a bit complicated, the reason we are using Canada Helps this year is to ensure all of our donors receive their tax receipts immediately, that administrative costs are minimal, and that we can track donations by rider, because riders get recognition and rewards the more they raise.
How Funds Will Be Used In 2014
For 2014, we are proud to announce that our efforts are directed 100% towards supporting the NCIC Clinical Trials Group in Kingston, Ontario who have included Canada in a very important clinical trial that is targeted at significantly improving the survival odds for pancreatic cancer patients that are eligible for surgery (aka the whipple procedure). It has been a pleasure to work with the NCIC Clinical Trials Group. They have been a very enthusiastic partner for 7 Days In May. Our Lake Riders will meet with the group in person prior to leaving Kingston on Monday, May 5th. As well, some of the people from the NCIC Clinical Trials Group are planning to ride out to meet our group on Sunday as we enter Kingston. From their perspective, the NCIC Clinical Trials Group is as excited about the notoriety as they are about the funding. This group works to save lives and are committed to improving survival rates for people across the country, but most of us don’t know about the great work they do. Watch our posts in the coming weeks, because we plan to “shout out” on just how great this team is – a dedicated team of which all Canadians should be proud.
The PA.6 Clinical Trial
PA.6 is a Clinical Trial studying the benefit of chemotherapy to help prevent recurrence for patients who have had surgery for pancreatic cancer. The PA.6 Trial is a joint Canadian-French international trial, led in Canada by the NCIC Clinical Trials Group, and currently being conducted at several cancer treatment centres across the country. The only known cure for patients diagnosed with pancreatic cancer is to remove the cancer by surgery. Unfortunately, even when surgery removes all of the cancer, the risk of recurrence is very high. Clinical trials have shown that cure rates are higher when surgery is followed promptly by chemotherapy, called adjuvant chemotherapy. The usual adjuvant chemotherapy consists of a drug called gemcitabine, typically given over a 6-month period.
The PA.6 study is an exciting clinical trial that is currently enrolling patients who have completed their surgery for pancreatic cancer. The purpose of the study is to compare gemcitabine to a new chemotherapy treatment called FOLFIRINOX that researchers believe may provide a higher chance of cure. This study is being done to determine whether FOLFIRINOX is more effective than gemcitabine in prolonging survival, and whether FOLFIRINOX is a safe and tolerable treatment.
There is a great deal of interest in PA.6 because researchers believe it is the most important adjuvant trial to help determine the best curative management for patients with pancreatic cancer. We encourage you to find out more about PA.6 and other clinical trials to see whether they may offer other possible treatment options for you.
For more information about the PA.6 Clinical Trial, please visit the clinical trials website: http://www.ctg.queensu.ca/public/Clinical_Trials/public_ph_3_trial_summary.html#PA6
For more information about the NCIC Clinical Trials Group, please visit their website: http://www.ctg.queensu.ca